Physician Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.1K Sell
14
-14
-50% -$3.05K ﹤0.01% 1352
2026
Q2
$5.46K Buy
28
+3
+12% +$622 ﹤0.01% 1055
2026
Q1
$5.61K Sell
25
-11
-31% -$2.74K ﹤0.01% 969
2025
Q4
$8.67K Sell
36
-26
-42% -$6.65K ﹤0.01% 820
2025
Q3
$17K Buy
62
+52
+520% +$14.2K ﹤0.01% 616
2025
Q2
$2.58K Buy
10
+2
+25% +$477 ﹤0.01% 963
2025
Q1
$1.79K Buy
8
+4
+100% +$934 ﹤0.01% 891
2024
Q4
$915 Buy
+4
New +$963 ﹤0.01% 964

Other funds holding RMD

Physician Wealth Advisors's RMD Position: Q3 2026 in Review

Physician Wealth Advisors reduced its ResMed (RMD) stake by 50% in Q3 2026, selling an estimated $3.05K and leaving 14 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Physician Wealth Advisors first reported a position in RMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $17K in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Physician Wealth Advisors held 14 shares of ResMed worth $3.1K as of Q3 2026.
  • Physician Wealth Advisors sold 14 ResMed shares in Q3 2026, an estimated $3.05K.
  • ResMed made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1352 holding.
  • Physician Wealth Advisors first reported a position in ResMed in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's ResMed position peaked at $17K in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.